7,225 results on '"Jeffrey A"'
Search Results
2. MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)
3. MP53-03 REAL-WORLD RESPONSE TO FIRST LINE PLATINUM-BASED CHEMOTHERAPY IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
4. MP39-14 EVALUATING THE CONTRIBUTION OF THE STANDARDIZED LETTER OF RECOMMENDATION TO A SUCCESSFUL MATCH IN UROLOGY RESIDENCY
5. MP75-10 NOCTURIA ACROSS THE HEART FAILURE CONTINUUM: RESULTS FROM AN OUTPATIENT UROLOGY POPULATION
6. PD02-06 COMPREHENSIVE GENOMIC PROFILING (CGP) OF CLINICAL T2-4N0M0 MUSCLE-INVASIVE BLADDER CANCER (MIBC) TREATED WITH NEOADJUVANT PEMBROLIZUMAB OR CISPLATIN-BASED CHEMOTHERAPY BEFORE RADICAL CYSTECTOMY (RC)
7. PD61-09 COMPARISON BETWEEN THREE CONTEMPORARY APPROACHES OF SINGLE-PORT ROBOTIC RADICAL PROSTATECTOMY: A REPORT FROM THE SINGLE-PORT ADVANCED RESEARCH CONSORTIUM INVOLVING 1800 PATIENTS
8. MP02-15 IS THE US NEWS AND WORLD REPORT'S SPEED IN TREATING TESTICULAR TORSION METRIC RELEVANT TO THE CARE OF EARLY NEONATES?
9. MP19-07 TOWARDS A TAILORED USE OF PSA DENSITY TO DECIDE WHEN TO AVOID PROSTATE BIOPSY IN MEN WITH PIRADS 3 LESIONS ACCORDING TO THE LOCATION OF THE INDEX LESION AT MP-MRI. RESULTS OF A LARGE, MULTI-INSTITUTIONAL SERIES
10. MP49-01 ADDITIVE UTILITY OF 68 GA-PROSTATE-SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN PROSTATE CANCER DIAGNOSIS: IS THERE A CASE FOR “SEEING IS BELIEVING”?
11. PD39-07 DIAGNOSTIC ACCURACY OF POST-CRYOABLATION MRI FOR RESIDUAL PROSTATE CANCER
12. MP41-06 URINE PROSTATE-DERIVED EXTRACELLULAR VESICLES: NANOSCALE FLOW CYTOMETRY UNVEILS A PROMISING BIOMARKER FOR DETECTING CLINICALLY SIGNIFICANT PROSTATE CANCER
13. MP66-02 INVESTIGATING ACTINIDIN AS A NOVEL COLLAGENASE ON HUMAN PEYRONIE’s DISEASE CELLS
14. PD53-04 PHOSPHATIDYLSERINE POSITIVE (PS + ) LIVE SPERM: AN INDICATOR OF FERTILITY IN PATIENTS WITH VARICOCELE
15. PD17-12 IS THERE A ROLE FOR C-11 PET-CT IN MEN WITH BIOCHEMICAL PROGRESSION OF PROSTATE CANCER AND NEGATIVE PSMA PET-CT?
16. V10-02 IMMEDIATE AND LONG-TERM OUTCOMES OF 3-INCISION ARTIFICIAL URINARY SPHINCTER PLACEMENT: CAN A THIRD INCISION REDUCE COMPLICATIONS RELATED TO THE PRESSURE REGULATING BALLOON AND PUMP?
17. HF01-12 A HISTORY OF RENAL TUMORS THROUGH THE PAGES OF ROBBINS PATHOLOGY AND CAMPBELL’S UROLOGY
18. PD05-02 DISPARITIES AFTER TIME-TO-OR IMPROVEMENTS IN TESTICULAR TORSION MAY GUIDE FUTURE QUALITY IMPROVEMENT
19. PD34-03 INTRAOPERATIVE TRANEXAMIC ACID IN RADICAL CYSTECTOMY: IMPACT ON BLEEDING, THROMBOEMBOLISM, AND CANCER-SPECIFIC SURVIVAL
20. MP12-16 NATIONAL TRENDS IN SAME DAY DISCHARGE FOR RADICAL PROSTATECTOMY: AN EVOLUTION IN PRACTICE PATTERNS
21. MP03-11 DOES RADIATION TIMING MATTER? ADJUVANT VS. SALVAGE RADIOTHERAPY EFFECTS ON ARTIFICIAL URINARY SPHINCTER SURVIVAL
22. MP25-04 13-YEAR INTERIM RESULTS FOR TRANSRECTALLY DELIVERED, OUTPATIENT MRI-GUIDED LASER FOCAL THERAPY OF PROSTATE CANCER IN A TREATMENT NAIVE COHORT
23. MP63-16 BACTERIA PROMOTES CALCIUM OXALATE CRYSTAL AGGREGATION THROUGH BIOFILM FORMATION
24. MP39-18 MEDICAL STUDENT UROLOGY SIMULATION LABORATORY INCREASES KNOWLEDGE OF AND INTEREST IN UROLOGY
25. MP71-20 BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
26. MP14-15 WHICH IS THE OPTIMAL MULTIMODAL MANAGEMENT OF PN1 PATIENTS WITH PSA PERSISTENCE AFTER RADICAL PROSTATECTOMY AND EXTENDED NODAL DISSECTION? RESULTS OF A LARGE, MULTI-INSTITUTIONAL DATABASE
27. MP05-09 A NOVEL METHOD TO IDENTIFY AGGRESSIVE PROSTATE CANCER WITH DNA-METHYLATION SIGNATURES FROM PROSTATE NEEDLE BIOPSY
28. MP52-14 PFANNENSTIEL SPECIMEN EXTRACTION DURING ROBOTIC RADICAL PROSTATECTOMY DECREASES RISK OF POSTOPERATIVE EXTRACTION SITE HERNIAS
29. MP37-13 WHEN AND WHY DO MEN REGRET HAVING RADICAL PROSTATECTOMY?
30. MP76-11 NO CLEAR INDICATION FOR PENILE IMPLANT REMOVAL AT THE TIME OF ARTIFICIAL URINARY SPHINCTER EXPLANTATION FOR CUFF EROSION
31. PD57-09 ADJUVANT OR EARLY SALVAGE RADIOTHERAPY IN NODE POSITIVE PROSTATE CANCER PATIENTS: DEVELOPMENT OF A NOVEL RISK SCORE TO IDENTIFY THE OPTIMAL CANDIDATE FOR EARLY INTENSIFICATION APPROACHES BASED ON A LARGE, MULTI-INSTITUTIONAL SERIES
32. MP36-16 PREDICTING CARDIOVASCULAR EVENTS IN PATIENTS WITH RENAL CELL CARCINOMA UNDERGOING NEPHRECTOMY: A MULTICENTRE HONG KONG PROSPECTIVE COHORT STUDY
33. PD34-10 FIRST RESULTS OF NURE-COMBO: a PHASE 2 STUDY OF NEOADJUVANT NIVOLUMAB (NIVO) AND NAB-PACLITAXEL (ABX) FOLLOWED BY POSTSURGICAL ADJUVANT NIVO IN PATIENTS (PTS) WITH MUSCLE-INVASIVE BLADDER CANCER (MIBC)
34. PD14-04 BLADDER CANCER CTC-PDX MODEL SYSTEMS PLATFORM FOR DISCOVERING DRUGGABLE MOLECULAR PATHWAYS TO OVERCOME CISPLATIN-BASED THERAPY RESISTANCE
35. MP06-15 THE OPTILUME® DRUG COATED BALLOON FOR RECURRENT ANTERIOR URETHRAL STRICTURES: ROBUST III STUDY 4-YEAR INTERIM RESULTS
36. PD48-01 EFFICACY OF NADOFARAGENE FIRADENOVEC-VNCG FOR PATIENTS WITH BACILLUS CALMETTE-GUÉRIN-UNRESPONSIVE NON-MUSCLE-INVASIVE BLADDER CANCER: FINAL RESULTS FROM A PHASE 3 TRIAL
37. PD45-04 DOES DRE ADD VALUE TO THE AUA PROSTATE CANCER RISK STRATIFICATION?
38. MP73-19 MULTI-INSTITUTIONAL LEARNING CURVE ANALYSIS OF THREE SINGLE-PORT ROBOTIC RADICAL PROSTATECTOMY APPROACHES FROM THE SPARC
39. MP46-06 HIGH-RISK PATIENTS UNDERGOING HoLEP HAVE FEWER INFECTIONS WITH A LONGER COURSE OF PREOPERATIVE ANTIBIOTICS: A RETROSPECTIVE MULTI-INSTITUTIONAL STUDY
40. MP17-10 IMPACT OF PLANNED RESEARCH GAP YEAR ON UROLOGY RESIDENCY MATCH SUCCESS
41. MP22-19 POST-OPERATIVE ANTIBIOTIC PROPHYLAXIS IN RADICAL CYSTECTOMY PATIENTS REDUCES GU INFECTIONS
42. MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY
43. MP34-13 HIGH NOCTURIA PREVALENCE IN PEOPLE LIVING WITH DISABILITIES: A NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY ANALYSIS
44. PD01-07 NATURAL HISTORY OF PN1 PROSTATE CANCER AFTER RADICAL PROSTATECTOMY: COMPETING RISK ANALYSIS FROM A LARGE MULTI-INSTITUTIONAL SERIES
45. MP57-10 BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF LOW-GRADE (LG) NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
46. MP47-19 EFFICACY AND SAFETY PROFILE OF TRANSDERMAL TESTOSTERONE FOR HYPOACTIVE SEXUAL DESIRE DISORDER: A SYSTEMATIC REVIEW AND META-ANALYSIS
47. PD55-03 PEDIATRIC UROLOGY VERSUS PEDIATRIC GENERAL SURGERY: A CROSS-SPECIALTY ANALYSIS OF PRACTICE PATTERNS AND SAFETY OUTCOMES FOR INTRA-ABDOMINAL ORCHIOPEXY
48. MP26-05 EFFECT OF ANTIHISTAMINE ON URETERAL STENT-RELATED SYMPTOMS: A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL
49. MP56-08 TREATMENT AFTER RENAL MASS THERMAL ABLATION TREATMENT FAILURE
50. MP41-14 HIGH DECIPHER SCORE DEFINES THE SUBGROUP MOST AT RISK OF METASTATIC PROGRESSION AMONG PATIENTS WITH LOWER GRADE TUMORS CLASSIFIED AS NCCN HIGH-RISK BASED ON ELEVATED PROSTATE-SPECIFIC ANTIGEN LEVEL ALONE
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.